SCHEMBL7779368

SCHEMBL7779368

CSc1ccc(-c2c(-c3ccc(S(N)(=O)=O)cc3)nn(CCN(C)C)c2C(F)(F)F)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 17/20 0.59
PTGS1 P23219 9/20 0.59
SLC6A4 P31645 3/20 0.38
PTGES O14684 1/20 0.36
HDAC3 O15379 1/20 0.36
PDPK1 O15530 1/20 0.36
CA12 O43570 1/20 0.36
PDE5A O76074 1/20 0.36
ABCB11 O95342 1/20 0.36
MT-CO2 P00403 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
LMNA P02545 1/20 0.36
CA3 P07451 1/20 0.36
CYP3A4 P08684 1/20 0.36
ALOX5 P09917 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
ADRB3 P13945 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780346 0.91 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL7777915 0.89 PTGS2 (0.75) PTGS2PTGS1CA12CA1CA2
SCHEMBL7779570 0.89 PTGS2 (0.62) PTGS2PTGS1PDPK1CA12MT-CO2
SCHEMBL7777885 0.89 PTGS2 (0.62) PTGS2PTGS1SLC6A4PTGESHDAC3
SCHEMBL7780881 0.88 PTGS2 (0.61) PTGS2PTGS1PDPK1CA12CA1
SCHEMBL7779473 0.88 PTGS2 (0.61) PTGS2PTGS1SLC6A4PTGESHDAC3
SCHEMBL7778122 0.88 PTGS2 (0.61) PTGS2PTGS1SLC6A4PTGESHDAC3
SCHEMBL7779779 0.87 PTGS2 (0.78) PTGS2PTGS1SLC6A4PTGESHDAC3
SCHEMBL7780599 0.86 PTGS2 (0.59) PTGS2PTGS1CA12CA1CA2
SCHEMBL7777897 0.86 PTGS2 (0.59) PTGS2PTGS1PDPK1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed